Boosting the case for a fourth dimension in drug clinical trials
Dec. 29, 2014
For years, the field of chronotherapeutics is patiently lurking as experimental findings that support the relevance of timing in drug administration continue to grow. A recent research paper published in Proceedings of the National Academy of Sciences may entail a significant boost for chronotherapy; one that could trigger wider and more systematic assessments of how circadian physiology influences our responses to therapeutics.